Clomiphene is banned in sports because it tricks the body into producing more testosterone, giving athletes a hormonal advantage. The World Anti-Doping Agency (WADA) classifies it under S4: Hormone and Metabolic Modulators, and it is prohibited at all times, both in and out of competition. This ban applies across all WADA-governed sports and appears on the 2026 Prohibited List alongside other drugs in the same class.
How Clomiphene Boosts Testosterone
Clomiphene was originally developed to treat female infertility by stimulating ovulation. But in men, it exploits the same hormonal feedback loop to raise testosterone levels significantly. Here’s how: estrogen normally signals the brain to slow down hormone production. Clomiphene blocks estrogen receptors in the hypothalamus, so the brain never gets that “slow down” signal. Without that brake, the hypothalamus ramps up its output, which triggers the pituitary gland to release more luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Those hormones then stimulate the testes to produce more testosterone.
In clinical studies of men with low testosterone, clomiphene raised average levels from about 235 to 438 ng/dL. Patients taking it also reported measurably improved sports performance on self-reported scales. Unlike injecting synthetic testosterone, clomiphene stimulates the body’s own production, which makes it appealing to athletes who want elevated hormone levels without the obvious red flag of synthetic testosterone in their blood.
Why WADA Considers It Performance-Enhancing
WADA bans a substance when it meets at least two of three criteria: it enhances (or has the potential to enhance) sports performance, it poses a health risk to the athlete, and it violates the spirit of sport. Clomiphene checks all three boxes.
The performance angle is straightforward. Higher testosterone levels increase muscle protein synthesis, improve recovery between training sessions, and can boost strength and power output. An athlete using clomiphene can maintain elevated testosterone while still technically producing it naturally, which creates an uneven playing field against competitors whose hormones sit at baseline levels.
Clomiphene also functions as a recovery tool after anabolic steroid cycles. When someone stops taking steroids, their natural testosterone production is suppressed, sometimes severely. Clomiphene “kickstarts” the body’s own hormone system, helping users bounce back faster. This makes it valuable not just as a standalone performance enhancer but as part of a broader doping strategy, allowing athletes to cycle off steroids and restore normal-looking hormone levels before testing.
It Stays Detectable for Months
One reason clomiphene is particularly risky for athletes who try to cheat is its extraordinarily long detection window. The drug is a mix of two molecular forms (isomers), and one of them, zuclomiphene, lingers in the body far longer than most banned substances. In a controlled study that tracked urine samples for months after short-term use, zuclomiphene remained detectable for 121 to over 261 days. That means a single course of clomiphene can show up in a urine test four to nine months later.
This extended detection window is partly why anti-doping agencies have been effective at catching clomiphene users. Athletes who assume the drug clears their system in a few weeks are often caught by out-of-competition testing months after use.
Health Risks of Clomiphene
Clomiphene carries real side effects that contribute to WADA’s health-risk concern. Vision problems are the most distinctive: between 1% and 10% of users experience blurred vision, double vision, light sensitivity, or seeing flashes and floaters. Post-marketing reports include more serious eye complications like optic neuritis, retinal hemorrhage, and temporary or prolonged vision loss.
Mood and mental health effects are also documented. Users may experience depression, anxiety, irritability, insomnia, and nervous tension. In rare post-marketing cases, psychosis has been reported. These risks are compounded when athletes use clomiphene without medical supervision, at higher doses, or for longer durations than clinical guidelines recommend.
Its Legitimate Medical Uses Don’t Grant Exemptions Easily
Clomiphene is FDA-approved for treating female infertility, and doctors prescribe it off-label to men with low testosterone. In clinical settings, it’s considered safe, tolerable, and effective for improving testosterone levels and symptoms of hypogonadism in men. This creates a genuine tension: a drug with legitimate medical value is completely off-limits in competition.
Athletes who need clomiphene for a valid medical reason can apply for a Therapeutic Use Exemption (TUE). WADA has published physician guidelines specifically addressing clomiphene use for female infertility, outlining what documentation is required: a full medical history, physical examination, lab results confirming the diagnosis, and a medical justification for why clomiphene was chosen over non-prohibited alternatives. TUEs are typically granted for one year and require documentation of treatment effects before renewal. For male athletes claiming low testosterone, the bar is even higher, since anti-doping authorities scrutinize these applications closely given the obvious performance benefit.
Athletes Still Get Caught
Despite the ban being well established, athletes continue testing positive. In one recent case, boxer Imam Khataev received a two-year suspension after an out-of-competition test in April 2024 detected clomiphene and its metabolites. His results were disqualified from that date forward, and his period of ineligibility runs through June 2027. The case was handled by the International Testing Agency on behalf of the International Boxing Association.
Khataev’s case is typical of clomiphene violations: a two-year ban, loss of competitive results, and public disclosure. Because clomiphene is classified as a “Specified Substance” under the WADA code, athletes can argue for a reduced sanction if they prove the use was unintentional, but they still face a minimum period of ineligibility. The combination of a long detection window and serious sanctions makes clomiphene one of the riskier substances an athlete can use if they’re subject to anti-doping testing.